Global Tonsil Cancer Treatment Market - 2022-2029

Global Tonsil Cancer Treatment Market - 2022-2029

Market Overview

The global tonsil cancer treatment market size was valued at US$ XX million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of XX% during the forecast period (2022-2029).

Throat cancer is a form of neck and head cancer that affects the larynx, vocal cords, and other throat parts. Cough, change in voice, painful throat, earache, and difficulty swallowing are just a few of the signs of throat cancer. There are two types of throat cancer: pharyngeal cancer and laryngeal cancer.

Market Dynamics

Increasing incidence of throat tumors and increasing awareness regarding throat cancer are the major factors driving the market's growth. The increasing smoking population is set to further enhance the overall market demand for throat cancer treatment during the forecast period.

Growing prevalence of throat cancer and increased awareness of the disease will drive the market growth

The growing prevalence of throat cancer and increased awareness of the disease is fueling the expansion of the throat cancer treatment market. Cancerous tumors that grow in your throat, voice box, or tonsils are throat cancer. Throat cancer can also affect the cartilage that serves as a lid for your large pipe. Tonsil cancer is a type of throat cancer that affects the tonsils positioned at the back of the throat. Throat cancer develops when the cells in your throat undergo genetic changes. These mutations allow cells to proliferate uncontrollably and to live after healthy cells would typically die. The collecting cells in your throat can create a tumor. It is unknown what causes the mutation that leads to throat cancer. Change in voice, Cough, sore throat, ear pain, and difficulty swallowing are some of the symptoms of throat cancer. The market for throat cancer treatment is growing as public awareness about the disease grows.

The market for throat cancer treatment is growing as the population of smokers grows. Smoking is the act of inhaling a chemical that has been burned and tasted before being absorbed into the bloodstream. The material used is tobacco leaves rolled into a small square of rice paper to form a small, spherical cylinder known as a cigarette. Because the combustion of dried plant leaves vaporizes and distributes active compounds into the lungs, where they are swiftly absorbed into the bloodstream and reach bodily tissue, smoking is predominantly used as a method of administration for recreational drug use.These factors are likely to boost the Tonsil Cancer Treatment market.

Side effects of chemotherapy medications is likely to hamper the market growth

Side effects of chemotherapy medications and a lack of accurate identification of the condition are two issues that are expected to slow the growth of the Throat Cancer Treatment Market.

COVID-19 Impact Analysis

COVID-19 has caused widespread disruption in healthcare workflows around the world. Various industries, including several sub-domains of healthcare, have been forced to close their doors because of the sickness temporarily. COVID-19 has also had a favorable impact on the market for oral cancer treatments. Many researchers shifted their focus to the study of COVID-19, and the disease was caused when it was initially discovered. Infection with the severe acute respiratory syndrome coronavirus 2 (SARSCoV2) causes viral pneumonia, which leads to acute respiratory distress syndrome. Its symptoms are similar to viral pneumonia and acute respiratory distress syndrome. SARSCoV2 is a continuing global danger since this virus family can evolve and infect non-immune people. However, in underdeveloped nations, most tonsil cancer cases are discovered in advanced stages, resulting in higher tonsil cancer morbidity and mortality. Dentists, in general, play a critical role in the early diagnosis of tonsil cancer by doing opportunistic screening when a patient comes in for routine throat care and quickly referring problematic lesions. Dental offices are closed, although the world is under lockdown during COVID-19. As a result, opportunities for oral cavity screening may be greatly interrupted. As a result, detection of malignant and potentially malignant lesions may be delayed, resulting in a missed diagnosis of mouth cancer or, at best, a later but late-stage diagnosis.

Segment Analysis

The chemotherapy segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

Chemotherapy, combination therapy, and single therapy treat throat cancer. Chemotherapy is predicted to have the largest market share shortly due to its treatment strategy that combines radiation therapy to lower tumor growth and an after-surgery process to destroy the tiny spots of cancer. Combination therapy is preferred to treat throat cancer because medications work through diverse pathways and reduce cancer cell resistance to drugs in combination therapy. Cisplatin and 5-FU are the most often used chemotherapy medications to treat throat tumors, but they have several adverse effects, including diarrhea, kidney damage, and heart difficulties.

Currently, research is being conducted to create innovative chemotherapies such as targeted medicines that employ EGFR inhibitors and angiogenesis inhibitors to treat throat cancer. Transoral robotic operations have recently gained popularity among physicians for tumor removal since they create small incisions on the body and perform the surgery precisely with fewer adverse effects. In radiation therapy, few doctors are attempting to kill cancer cells using proton beam therapy because it causes less damage to the tissues than X-rays.

Geographical Analysis

North America region holds the largest market share of the global Tonsil Cancer Treatment market

The North American tonsil cancer treatment market accounted for the lion's share because of the widespread use of advanced treatment procedures. According to the National Cancer Institute (NCI), around 1.1 percent of adults will be diagnosed with pharyngeal cancer and 0.4 percent with laryngeal cancer at some point in their lives. Tobacco usage, excessive alcohol use, HPV infection, and chewing betel juice are the leading causes of throat cancer. According to the American Cancer Society (ACS), around 13,430 new instances of laryngeal cancer were detected in 2016, with 79 percent of the cases being men and 21 percent being women. Throat cancer is more common in men than women, which is most likely due to their smoking habits.

North American region is developing novel treatment and diagnostic methods. Furthermore, rising death rates increased patient awareness of the availability of new tonsil cancer treatment procedures. Advanced healthcare infrastructure is expected to drive the growth of the Tonsil Cancer Treatment market in North America.

Competitive Landscape

The tonsil cancer treatment market is a highly competitive presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include Bristol-Myers Squibb, IGM Pharma, Sanofi, Sun Pharmaceuticals, South delhi Pharma, Keytruda, Pfizer, Sandoz, Accordhealthcare, among others. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the tonsil cancer treatment market globally. For instance, in 2017, Bristol-Myers Squibb Receives a Positive CHMP Opinion Recommending Opdivo (nivolumab) for the Treatment of Squamous Cell Cancer of the Head and Neck in Adults Progressing on or Following Platinum-Based Therapy.

Pfizer Inc

Overview:

Pfizer Inc. discovers, manufactures, develops and commercializes biopharmaceuticals. The company sells medications to treat various ailments, including cardiovascular, metabolic, and pain disorders, cancer, inflammation, immunological disorders, and uncommon diseases. It also offers contract manufacturing services, including sterile injectable pharmaceuticals, biosimilars, and active pharmaceutical ingredients (APIs). Wholesalers, merchants, hospitals, clinics, government agencies, and pharmacies sell Pfizer's products.

Product Portfolio:

Methotrexate: Methotrexate is used to treat certain types of cancer and severe psoriasis and rheumatoid arthritis that have not responded to conventional treatments. It can also be used to treat rheumatoid arthritis in children. Methotrexate belongs to the antimetabolite class of medicines. It suppresses the immune system while reducing or preventing the proliferation of cancer cells.

The global tonsil cancer treatment market report would provide access to an approximately 40+ market data table, 45+ figures, and in the range of 180-200 (approximate) pages.